medigraphic.com
ISSN 0185-3325 (Print)
Órgano Oficial del Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz

2024, Number 5

<< Back Next >>

Salud Mental 2024; 47 (5)

Quality of Life and Medication Therapy Adherence in Primary Healthcare: focus on common mental disorders

Inocenti MA, Longo BT, Bier SNT, Giacchero VKG, de Souza J, dos Santos MA, Pillon SC

Language: English
References: 39
Page: 219-228
PDF size: 188.73 Kb.


ABSTRACT

Introduction. Medication therapy adherence is a challenge in the clinical practice of health providers. Objective. To identify predictors of nonadherence to medication therapy and quality of life (QoL) in medication users. Method. A cross-sectional analytical study was conducted at five primary health care (PHC) units in Brazil. Standardized tools included the Self-Reporting Questionnaire, Measurement of Treatment Adherence, and World Health Organization Quality-of-Life-Bref, in addition to a sociodemographic and treatment-related questionnaire. Results. Participants with common mental disorders (CMDs) who used psychotropic medication were more likely to be nonadherent to medication treatment. Sociodemographic variables, presence of a CMD, and psychotropic medication use were key predictors of lower QoL in patients treated at PHC. Discussion and conclusion. The findings of this study could inform interventions designed to improve medication therapy adherence and train public health care professionals to enhance health care.


REFERENCES

  1. Ausín, B., Zamorano, A., & Muñoz, M. (2020). Relationship between quality of lifeand sociodemographic, physical and mental health variables in people over 65in the community of Madrid. International Journal of Environmental Researchand Public Health, 17(22), 1-11. https://doi.org/10.3390/ijerph17228528

  2. Barros, F. C., Matijasevich, A., Santos, I. S., Horta, B. L., da Silva, B. G. C., Munhoz,T. N., Fazel, S., Stein, A., Pearson, R. M., Anselmi, L., & Rohde, L. A. (2018).Social inequalities in mental disorders and substance misuse in young adults:A birth cohort study in Southern Brazil. Social Psychiatry and PsychiatricEpidemiology, 53(7), 717-726. https://doi.org/10.1007/s00127-018-1526-x

  3. Bielderman, A., de Greef, M. H. G., Krijnen, W. P., & van der Schans, C. P. (2015).Relationship between socioeconomic status and quality of life in older adults:a path analysis. Quality of Life Research, 24(7), 1697-1705. https://doi.org/10.1007/s11136-014-0898-y

  4. Brody, D. J., & Gu, Q. (2020). Antidepressant Use Among Adults: United States,2015-2018. NCHS Data Brief, 377, 1-8.

  5. Caron, J., Cargo, M., Daniel, M., & Liu, A. (2019). Predictors of Quality of Life inMontreal, Canada: A Longitudinal Study. Community Mental Health Journal,55(2), 189-201. https://doi.org/10.1007/s10597-018-0340-y

  6. Delgado, A. B., & Lima, M. L. (2001). Contributo para a validação concorrente deuma medida de adesão aos tratamentos. Psicologia, Saúde & Doenças, 2(2),81-100. Retrieved from https://www.researchgate.net/publication/237033567_Contributo_para_a_avalicao_concorrente_de_uma_medida_de_adesao_aos_tratamentos

  7. El Abdellati, K., De Picker, L., & Morrens, M. (2020). Antipsychotic TreatmentFailure: A Systematic Review on Risk Factors and Interventions for TreatmentAdherence in Psychosis. Frontiers in Neuroscience, 14, 531763. https://doi.org/10.3389/fnins.2020.531763

  8. Estrela, M., Herdeiro, M. T., Ferreira, P. L., & Roque, F. (2020). The use ofantidepressants, anxiolytics, sedatives and hypnotics in Europe: Focusing onmental health care in portugal and prescribing in older patients. InternationalJournal of Environmental Research and Public Health, 17(22), 1-12. https://doi.org/10.3390/ijerph17228612

  9. Ferretti, F., Castanha, A. C., Padoan, E. R., Lutinski, J., & Silva, M. R. da. (2018).Quality of life in the elderly with and without chronic pain. Brazilian Journal ofPain, 1(2), 111-115. https://doi.org/10.5935/2595-0118.20180022

  10. Fleck, M. P. A., Louzada, S., Xavier, M., Chachamovich, E., Vieira, G., Santos, L.,& Pinzon, V. (2000). ApplicationofthePortugueseversion of the abbreviatedinstrumentof quality life WHOQOL-bref. Revista de Saude Publica, 34(2), 178-183. https://doi.org/10.1590/s0034-89102000000200012

  11. Gast, A., & Mathes, T. (2019). Medication adherence influencing factors - An(updated) overview of systematic reviews. Systematic Reviews, 8(1), 1-17.https://doi.org/10.1186/s13643-019-1014-8

  12. González-Blanch, C., Hernández-de-Hita, F., Muñoz-Navarro, R., Ruíz-Rodríguez,P., Medrano, L. A., & Cano-Vindel, A. (2018). The association betweendifferent domains of quality of life and symptoms in primary care patients withemotional disorders. Scientific Reports, 8(1), 1-10. https://doi.org/10.1038/s41598-018-28995-6

  13. Gupta, P., Patel, P., Štrauch, B., Lai, F. Y., Akbarov, A., Marešová, V., White, C.M., Petrák, O., Gulsin, G. S., Patel, V., Rosa, J., Cole, R., Zelinka, T., Holaj,R., Kinnell, A., Smith, P. R., Thompson, J. R., Squire, I., Widimský, J., ...Tomaszewski, M. (2017). Risk Factors for Nonadherence to AntihypertensiveTreatment. Hypertension, 69(6), 1113-1120. https://doi.org/10.1161/HYPERTENSIONAHA.116.08729

  14. Ismail, L. M. N., Selim, M. A.-A., & Elkhashab, S. O. Y. (2017). Factors affectingmedication adherence among patients with rheumatic disorders. Journal ofNursing Education and Practice, 7(8), 7. https://doi.org/10.5430/jnep.v7n8p7

  15. Jin, H., Kim, Y., & Rhie, S. J. (2016). Factors affecting medication adherence inelderly people. Patient Preference and Adherence, 10, 2117-2125. https://doi.org/10.2147/PPA.S118121

  16. Kim, J., Combs, K., Downs, J., & Tillman III, F. (2018). Medication Adherence: TheElephant in the Room. US Pharmacist, 43(1), 30-34. Retrieved from https://www.uspharmacist.com/article/medication-adherence-the-elephant-in-the-room

  17. Kopp, M., Fleischhacker, W. W., Stürz, K., Ruedl, G., Kumnig, M., & Rumpold, G.(2011). Poor health behaviour and reduced quality of life of people treated withpsychotropic drugs. Human Psychopharmacology: Clinical and Experimental,26(2), 161-167. https://doi.org/10.1002/hup.1190

  18. Kroenke, K., Outcalt, S., Krebs, E., Bair, M. J., Wu, J., Chumbler, N., & Yu,Z. (2013). Association between anxiety, health-related quality of lifeand functional impairment in primary care patients with chronic pain.General Hospital Psychiatry, 35(4), 359-365. https://doi.org/10.1016/j.genhosppsych.2013.03.020

  19. Lam, W. Y., & Fresco, P. (2015). Medication Adherence Measures: AnOverview. BioMed Research International, 2015, 217047. https://doi.org/10.1155/2015/217047

  20. Lee, K. H., Xu, H., & Wu, B. (2020). Genderdifferences in quality of life amongcommunity-dwelling older adults in low- and middle-income countries: resultsfrom the Study on globalAGEing and adult health (SAGE). BMC PublicHealth,20(1), 114. https://doi.org/10.1186/s12889-020-8212-0

  21. Magin, P., Tapley, A., Dunlop, A. J., Davey, A., van Driel, M., Holliday, E., Morgan,S., Henderson, K., Ball, J., Catzikiris, N., Mulquiney, K., Spike, N., Kerr, R., & Holliday, S. (2018). Changes in Australian Early-Career General Practitioners’Benzodiazepine Prescribing: A Longitudinal Analysis. Journal of GeneralInternal Medicine, 33(10), 1676-1684. https://doi.org/10.1007/s11606-018-4577-5

  22. Malhotra, S., & Shah, R. (2015). Women and mental health in India: An overview.Indian Journal of Psychiatry, 57(Supp), 205-211. https://doi.org/10.4103/0019-5545.161479

  23. Mari, J. D. J., & Williams, P. (1986). A Validity Study of a Psychiatric ScreeningQuestionnaire (SRQ-20) in primary care in the city of Sao Paulo. BritishJournal of Psychiatry, 148, 23-26. https://doi.org/10.1192/bjp.148.1.23

  24. Martin, L. R., Feig, C., Maksoudian, C. R., Wysong, K., & Faasse, K. (2018). Aperspective on nonadherence to drug therapy: Psychological barriers andstrategies to overcome nonadherence. Patient Preference and Adherence, 12,1527-1535. https://doi.org/10.2147/PPA.S155971

  25. Miasso, A. I., Telles Filho, P. C. P., Borges, T. L., Pereira Júnior, A. C., Vedana, K. G.G., Shasanmi, R., & Escobar Gimenes, F. R. (2016). Adherence to PsychotropicMedications and Associated Factors in Primary Health Care. Issues in MentalHealth Nursing, 37(10), 775-783. https://doi.org/10.1080/01612840.2016.1214854

  26. Miasso, A. I., Telles Filho, P. C. P., Borges, T. L., Pereira Junior, A. C., Vedana, K.G. G., Shasanmi, R. O., & Gimenes, F. R. E. (2017). Quality of Life in Brazil’sFamily Health Strategy: Common Mental Disorders, Use of Psychotropic Drugsand Sociodemographic Factors. Archives of Psychiatric Nursing, 31(1), 68-72.https://doi.org/10.1016/j.apnu.2016.08.005

  27. Ogawa, Y., Takeshima, N., Hayasaka, Y., Tajika, A., Watanabe, N., Streiner, D., &Furukawa, T. A.. (2019). Antidepressants Plus Benzodiazepines for Adults withMajor Depression. The Cochrane Database of Systematic Reviews, 101(9), 527-528. https://doi.org/10.1002/14651858.CD001026.pub2

  28. Pereira Júnior, A. do C., Miasso, A. I., Telles Filho, P. C. P., Castilho, E. C. D., &Vedana, K. G. G. (2021). Evaluation of Quality of Life of Primary Health CarePatients in Brazil: Influence of Drug Interactions, Common Mental Disorders,and Use of Psychiatric Medication. Community Mental Health Journal, 58(2),240-248. https://doi.org/10.1007/s10597-021-00815-8

  29. Pino-Sedeño, T. Del, Peñate, W., Cuevas, C. D. Las, Valcarcel-Nazco, C., Fumero,A., Serrano-Pérez, P. G., Acosta-Artiles, F. J., Ramos-García, V., León-Salas,B., Bejarano-Quisoboni, D., & Trujillo-Martín, M. M. (2019). Effectivenessand cost-effectiveness of a multicomponent intervention to improve medicationadherence in people with depressive disorders - mapdep: A study protocol for acluster randomized controlled trial. Patient Preference and Adherence, 13, 309-319. https://doi.org/10.2147/PPA.S172963

  30. Prakash, J., Yadav, Y., Srivastava, K., & Madhusudan, T. (2019). Psychosocialcorrelates of medication adherence in patients with depressive illness. IndustrialPsychiatry Journal, 28(1), 135. https://doi.org/10.4103/ipj.ipj_78_19

  31. Semahegn, A., Torpey, K., Manu, A., Assefa, N., Tesfaye, G., & Ankomah, A. (2018).Psychotropic medication non-adherence and associated factors among adultpatients with major psychiatric disorders: A protocol for a systematic review.Systematic Reviews, 7(1), 1-5. https://doi.org/10.1186/s13643-018-0676-y

  32. Semahegn, A., Torpey, K., Manu, A., Assefa, N., Tesfaye, G., & Ankomah, A.(2020). Psychotropic medication non-adherence and its associated factorsamong patients with major psychiatric disorders: A systematic review and metaanalysis. Systematic Reviews, 9(1), 1-18. https://doi.org/10.1186/s13643-020-1274-3

  33. Soósová, M. S. (2016). Determinants of quality of life in the elderly. CentralEuropean Journal of Nursing and Midwifery, 7(3), 484-493. https://doi.org/10.15452/CEJNM.2016.07.0019

  34. Tanguay Bernard, M. M., Luc, M., Carrier, J. D., Fournier, L., Duhoux, A., Côté,E., Lessard, O., Gibeault, C., Bocti, C., & Roberge, P. (2018). Patterns ofbenzodiazepines use in primary care adults with anxiety disorders. Heliyon,4(7), e00688. https://doi.org/10.1016/j.heliyon.2018.e00688

  35. Tavakoli-Fard, N., Mortazavi, S. A., Kuhpayehzadeh, J., & Nojomi, M. (2016). Qualityof life, Work ability and other important indicators of women’s occupationalhealth. International Journal of Occupational Medicine and EnvironmentalHealth, 29(1), 77-84. https://doi.org/10.13075/ijomeh.1896.00329

  36. The WHOQOL Group. (1998). Development of the World Health OrganizationWHOQOL-BREF quality of life assessment. Psychological Medicine, 28(3),551-558. https://doi.org/10.1017/s0033291798006667

  37. Wand, T. (2019). Is it time to end our complicity with pharmacocentricity?International Journal of Mental Health Nursing, 28(1), 3-6. https://doi.org/10.1111/inm.12554

  38. World Health Organization [WHO]. (2021). Primary health care. https://www.who.int/news-room/fact-sheets/detail/primary-health-care

  39. Zheng, F., Duan, Y., Li, J., Lai, L., Zhong, Z., Hu, M., & Ding, S. (2019). Somaticsymptoms and their association with anxiety and depression in Chinese patientswith cardiac neurosis. Journal of International Medical Research, 47(10), 4920-4928. https://doi.org/10.1177/0300060519869711




2020     |     www.medigraphic.com